Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (241-250 of 287) with videos related to

Pageof 29
Sort By:
Gastroenterology|February 14, 2012
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trialPaul Rutgeerts, Gert Van Assche, William J Sandborn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2011
Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's diseaseMatthias Jürgens, Jestinah M Mahachie John, Isabelle Cleynen, et al.
Inflammatory Intestinal Diseases|June 14, 2021
What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing CountriesRichard B Gearry, Andrew M McCombie, Morten Vatn, et al.
Journal of Crohn'S & Colitis|May 20, 2016
Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of ColitisChristine Breynaert, Magali de Bruyn, Ingrid Arijs, et al.
Inflammatory Bowel Diseases|May 3, 2008
Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's diseaseJohn P Burke, Marc Ferrante, Karen Dejaegher, et al.
Journal of Crohn'S & Colitis|September 1, 2018
Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal StrategiesShomron Ben-Horin, Gert Van Assche, Yehuda Chowers, et al.
Journal of Crohn'S & Colitis|January 19, 2019
Gene and Mirna Regulatory Networks During Different Stages of Crohn's DiseaseSare Verstockt, Gert De Hertogh, Jan Van der Goten, et al.
Inflammatory Bowel Diseases|November 7, 2007
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseasesChristoph Gasche, Arnold Berstad, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis|January 21, 2012
Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programmeMarc Ferrante, Konstantinos Karmiris, Evan Newnham, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2019
Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative ColitisOmoniyi J Adedokun, Zhenhua Xu, Colleen Marano, et al.
Pageof 29

Showing results (241-250 of 287) with videos related to

Sort By:
Pageof 29
Gastroenterology|February 14, 2012
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trialPaul Rutgeerts, Gert Van Assche, William J Sandborn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2011
Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's diseaseMatthias Jürgens, Jestinah M Mahachie John, Isabelle Cleynen, et al.
Inflammatory Intestinal Diseases|June 14, 2021
What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing CountriesRichard B Gearry, Andrew M McCombie, Morten Vatn, et al.
Journal of Crohn'S & Colitis|May 20, 2016
Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of ColitisChristine Breynaert, Magali de Bruyn, Ingrid Arijs, et al.
Inflammatory Bowel Diseases|May 3, 2008
Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's diseaseJohn P Burke, Marc Ferrante, Karen Dejaegher, et al.
Journal of Crohn'S & Colitis|September 1, 2018
Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal StrategiesShomron Ben-Horin, Gert Van Assche, Yehuda Chowers, et al.
Journal of Crohn'S & Colitis|January 19, 2019
Gene and Mirna Regulatory Networks During Different Stages of Crohn's DiseaseSare Verstockt, Gert De Hertogh, Jan Van der Goten, et al.
Inflammatory Bowel Diseases|November 7, 2007
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseasesChristoph Gasche, Arnold Berstad, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis|January 21, 2012
Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programmeMarc Ferrante, Konstantinos Karmiris, Evan Newnham, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2019
Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative ColitisOmoniyi J Adedokun, Zhenhua Xu, Colleen Marano, et al.
Pageof 29